R. Chin

发表

Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosis.

P. Angus, J. Silke, J. Torresi, 2014, The Journal of general virology.

Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.

P. Angus, J. Torresi, E. Lim, 2012, World journal of gastroenterology.

Hepatitis C‐induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents

P. Angus, J. Silke, J. Torresi, 2016, Journal of viral hepatitis.

Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus.

I. Barr, L. Brown, D. Jackson, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses

D. Jackson, J. Torresi, L. Earnest-Silveira, 2012, PloS one.

Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin.

H. Drummer, J. Torresi, S. Bowden, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals.

M. Loudovaris, H. Prince, L. Brown, 2010, Journal of hepatology.

Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis.

H. Zentgraf, J. Torresi, E. Gowans, 2007, Journal of hepatology.

ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.

P. Angus, I. Alexander, J. Torresi, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation

P. Angus, J. Silke, J. Torresi, 2015, PloS one.

In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to (−)-β-d-2,6-Diaminopurine Dioxolane and 2′-Fluoro-5-Methyl-β-l-Arabinofuranosyluracil

M. Manns, C. Trautwein, H. Isom, 2001, Antimicrobial Agents and Chemotherapy.

Subcellular Mislocalization of Mutant Hepatitis B X Proteins Contributes to Modulation of STAT/SOCS Signaling in Hepatocellular Carcinoma

H. Zentgraf, R. Kandolf, J. Torresi, 2009, Intervirology.

Torcitabine and Valtorcitabine

J. Torresi, R. Chin, 2010 .

In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.

M. Manns, C. Trautwein, H. Isom, 2001, Antimicrobial agents and chemotherapy.

Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus.

H. Zentgraf, J. Silke, J. Torresi, 2010, Virus research.

Treatment of chronic hepatitis B: current challenges and future directions

S. Locarnini, R. Chin, 2003, Reviews in medical virology.

Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver.

H. Zentgraf, N. Bektas, R. Kandolf, 2010, Virus research.

Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line.

S. Ralph, A. Mesalam, D. Jackson, 2016, The Journal of general virology.

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus

C. Begley, M. Pellegrini, J. Silke, 2015, Proceedings of the National Academy of Sciences.

Failure of Lamivudine to Reverse Hepatitis B Virus-Associated Changes in ERK, Akt and Cell Cycle Regulatory Proteins

H. Zentgraf, J. Torresi, S. Bowden, 2008, Antiviral therapy.

Japanese B Encephalitis: An Overview of the Disease and Use of Chimerivax-JE as a Preventative Vaccine

J. Torresi, R. Chin, 2013, Infectious Diseases and Therapy.